Phreesia Class Action Lawsuit Deadline Approaches for Investors
Law firm Faruqi & Faruqi reminds Phreesia investors of the deadline to seek lead plaintiff status in a securities class action lawsuit. The suit alleges misleading statements about growth potential.
The law firm Faruqi & Faruqi, LLP is investigating potential claims against Phreesia, Inc. (Phreesia) and is reminding investors of the July 13, 2026 deadline to seek lead plaintiff status in a federal securities class action filed against the company.
The complaint alleges that Phreesia and its executives violated federal securities laws by making false and misleading statements and failing to disclose material adverse facts. Specifically, the suit claims the company provided overly positive statements about its growth potential and contributions from its AccessOne acquisition, while concealing information about slowing demand and weakened revenue streams, particularly in its Network Solutions segment related to pharmaceutical marketing commitments.
Following the market close on March 30, 2026, Phreesia announced significantly reduced revenue growth projections for fiscal year 2027. The company attributed this shortfall to macroeconomic factors, including "worsening visibility" and weaker pharmaceutical marketing commitments. Phreesia's stock price subsequently dropped approximately 27% from its closing price of $11.41 on March 30, 2026, to $8.38 on March 31, 2026.
Investors who purchased or acquired Phreesia securities between May 8, 2025, and March 30, 2026, and suffered losses are encouraged to contact Faruqi & Faruqi. The firm is also seeking information from potential whistleblowers, former employees, and others with knowledge of Phreesia's conduct.